Amali E. Samarasinghe

1.3k total citations
42 papers, 919 citations indexed

About

Amali E. Samarasinghe is a scholar working on Physiology, Immunology and Epidemiology. According to data from OpenAlex, Amali E. Samarasinghe has authored 42 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 14 papers in Immunology and 13 papers in Epidemiology. Recurrent topics in Amali E. Samarasinghe's work include Asthma and respiratory diseases (26 papers), Influenza Virus Research Studies (11 papers) and Respiratory viral infections research (10 papers). Amali E. Samarasinghe is often cited by papers focused on Asthma and respiratory diseases (26 papers), Influenza Virus Research Studies (11 papers) and Respiratory viral infections research (10 papers). Amali E. Samarasinghe collaborates with scholars based in United States, United Kingdom and Germany. Amali E. Samarasinghe's co-authors include Kim S. LeMessurier, Scott A. Hoselton, Jane M. Schuh, Jonathan A. McCullers, Swantje Liedmann, John D. Snyder, Peter Vogel, Nicholas Morin, Rossana C. N. Melo and Julia L. Hurwitz and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Journal of Virology.

In The Last Decade

Amali E. Samarasinghe

39 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amali E. Samarasinghe United States 18 352 344 332 174 159 42 919
Qun Wu United States 21 400 1.1× 488 1.4× 262 0.8× 74 0.4× 266 1.7× 47 1.4k
Kerstin Wanke Switzerland 11 368 1.0× 261 0.8× 193 0.6× 113 0.6× 126 0.8× 14 1.0k
Li‐Yin Hung United States 15 239 0.7× 571 1.7× 142 0.4× 96 0.6× 223 1.4× 32 1.2k
Florêncio Figueiredo Brazil 17 91 0.3× 404 1.2× 454 1.4× 253 1.5× 64 0.4× 34 1.1k
Monica Borghi Italy 16 106 0.3× 178 0.5× 170 0.5× 150 0.9× 92 0.6× 30 710
Yoshiyuki Mishima Japan 24 164 0.5× 541 1.6× 236 0.7× 153 0.9× 123 0.8× 66 1.5k
Shinji Toki United States 18 486 1.4× 632 1.8× 131 0.4× 77 0.4× 208 1.3× 44 1.2k
Jun‐Pyo Choi South Korea 19 212 0.6× 236 0.7× 118 0.4× 69 0.4× 157 1.0× 33 1.0k
Kunio Yamaoka Japan 15 252 0.7× 279 0.8× 139 0.4× 188 1.1× 71 0.4× 29 890
Sabine Zeller Switzerland 8 213 0.6× 309 0.9× 125 0.4× 89 0.5× 53 0.3× 10 926

Countries citing papers authored by Amali E. Samarasinghe

Since Specialization
Citations

This map shows the geographic impact of Amali E. Samarasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amali E. Samarasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amali E. Samarasinghe more than expected).

Fields of papers citing papers by Amali E. Samarasinghe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amali E. Samarasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amali E. Samarasinghe. The network helps show where Amali E. Samarasinghe may publish in the future.

Co-authorship network of co-authors of Amali E. Samarasinghe

This figure shows the co-authorship network connecting the top 25 collaborators of Amali E. Samarasinghe. A scholar is included among the top collaborators of Amali E. Samarasinghe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amali E. Samarasinghe. Amali E. Samarasinghe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dendooven, Arnaud, Stéphane Esnault, Marie Paule Jacob, et al.. (2025). Evolution of Blood Innate Immune Cell Phenotypes Following SARS-CoV-2 Infection in Hospitalized Patients with COVID-19. Cells. 14(14). 1093–1093.
2.
Sharma, Akshat & Amali E. Samarasinghe. (2024). “It’s a Trap”: Eosinophils Caught between Pro- and Anti-inflammatory Responses. American Journal of Respiratory Cell and Molecular Biology. 72(1). 3–5.
3.
Williams, Evan P., Piroon Jenjaroenpun, Thidathip Wongsurawat, et al.. (2023). Dissecting Phenotype from Genotype with Clinical Isolates of SARS-CoV-2 First Wave Variants. Viruses. 15(3). 611–611.
4.
Samarasinghe, Amali E., et al.. (2023). Host mitochondria: more than an organelle in SARS-CoV-2 infection. Frontiers in Cellular and Infection Microbiology. 13. 1228275–1228275. 15 indexed citations
5.
Samarasinghe, Amali E., et al.. (2022). Impact of Therapeutics on Unified Immunity During Allergic Asthma and Respiratory Infections. SHILAP Revista de lepidopterología. 3. 852067–852067. 4 indexed citations
6.
Silva, Thiago P., et al.. (2022). Mitochondrial Population in Mouse Eosinophils: Ultrastructural Dynamics in Cell Differentiation and Inflammatory Diseases. Frontiers in Cell and Developmental Biology. 10. 836755–836755. 13 indexed citations
7.
LeMessurier, Kim S., et al.. (2020). Respiratory Barrier as a Safeguard and Regulator of Defense Against Influenza A Virus and Streptococcus pneumoniae. Frontiers in Immunology. 11. 3–3. 60 indexed citations
8.
LeMessurier, Kim S. & Amali E. Samarasinghe. (2019). Eosinophils: Nemeses of Pulmonary Pathogens?. Current Allergy and Asthma Reports. 19(8). 36–36. 27 indexed citations
9.
Hatami, Elham, Prashanth K.B. Nagesh, Pallabita Chowdhury, et al.. (2018). Tannic Acid-Lung Fluid Assemblies Promote Interaction and Delivery of Drugs to Lung Cancer Cells. Pharmaceutics. 10(3). 111–111. 17 indexed citations
10.
Snyder, John D., et al.. (2018). Macrophage CD14 impacts immune defenses against influenza virus in allergic hosts. Microbial Pathogenesis. 127. 212–219. 7 indexed citations
11.
LeMessurier, Kim S., et al.. (2018). Chronic features of allergic asthma are enhanced in the absence of resistin-like molecule-beta. Scientific Reports. 8(1). 7061–7061. 11 indexed citations
12.
Samarasinghe, Amali E., Rossana C. N. Melo, Susu Duan, et al.. (2017). Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus. The Journal of Immunology. 198(8). 3214–3226. 119 indexed citations
13.
Apiwattanakul, Nopporn, et al.. (2017). Immune responses to fungal aeroallergen in Heligmosomoides polygyrus-infected mice vary by age. Cellular Immunology. 317. 26–36. 2 indexed citations
14.
Hrincius, Eike R., Swantje Liedmann, David Finkelstein, et al.. (2015). Acute Lung Injury Results from Innate Sensing of Viruses by an ER Stress Pathway. Cell Reports. 11(10). 1591–1603. 48 indexed citations
15.
Ghosh, Sumit, Amali E. Samarasinghe, Scott A. Hoselton, Glenn Dorsam, & Jane M. Schuh. (2014). Hyaluronan deposition and co-localization with inflammatory cells and collagen in a murine model of fungal allergic asthma. Inflammation Research. 63(6). 475–484. 15 indexed citations
16.
Samarasinghe, Amali E., Scott A. Hoselton, & Jane M. Schuh. (2010). Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs. Regulatory Peptides. 164(2-3). 151–157. 17 indexed citations
17.
Hoselton, Scott A., et al.. (2010). An inhalation model of airway allergic response to inhalation of environmentalAspergillus fumigatusconidia in sensitized BALB/c mice. Medical Mycology. 48(8). 1056–1065. 47 indexed citations
18.
Samarasinghe, Amali E., Scott A. Hoselton, & Jane M. Schuh. (2010). The absence of VPAC2 leads to aberrant antibody production in Aspergillus fumigatus sensitized and challenged mice. Peptides. 32(1). 131–137. 19 indexed citations
19.
Samarasinghe, Amali E., Scott A. Hoselton, & Jane M. Schuh. (2010). The absence of the VPAC2 receptor does not protect mice from Aspergillus induced allergic asthma. Peptides. 31(6). 1068–1075. 14 indexed citations
20.
Hoselton, Scott A., et al.. (2007). Creation and Characterization of an IgG1-Type Monoclonal Antibody Against Intact Aspergillus Fumigatus Conidia. Hybridoma. 26(4). 251–254. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qun Wu Breakdown of academic impact, for papers by Kerstin Wanke Breakdown of academic impact, for papers by Li‐Yin Hung Breakdown of academic impact, for papers by Florêncio Figueiredo Breakdown of academic impact, for papers by Monica Borghi Breakdown of academic impact, for papers by Yoshiyuki Mishima Breakdown of academic impact, for papers by Shinji Toki Breakdown of academic impact, for papers by Jun‐Pyo Choi Breakdown of academic impact, for papers by Kunio Yamaoka Breakdown of academic impact, for papers by Sabine Zeller
Rankless by CCL
2026